Impact of thalidomide-based induction regimens on PBSC harvest in multiple myeloma patients

被引：0
|
作者：
Lanska, M. [1 ]
Maisnar, V. [1 ]
Radocha, J. [1 ]
Zak, P. [1 ]
Zavrelova, A. [1 ]
Blaha, M. [1 ]
Horacek, J. [1 ]
Doskocilova, K. [1 ]
Maly, J. [1 ]
机构：
[1] Teaching Hosp, Hradec Kralove, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [41] Thalidomide and thrombosis in patients with multiple myeloma
    Camba, L
    Peccatori, J
    Pescarollo, A
    Tresoldi, M
    Corradini, P
    Bregni, M
    HAEMATOLOGICA, 2001, 86 (10) : 1108 - 1109
  • [42] Clinical impact of bortezomib in frontline regimens for patients with multiple myeloma
    Manochakian, Rami
    Miller, Kena C.
    Chanan-Khan, Asher A.
    ONCOLOGIST, 2007, 12 (08): : 978 - 990
  • [43] Thalidomide in elderly patients with multiple myeloma
    Kusumi, Eiji
    Matsumura, Tomoko
    Yuji, Koichiro
    Tanaka, Yuji
    Kami, Masahiro
    LANCET, 2006, 367 (9527): : 1977 - 1977
  • [44] Life-threatening bowel perforation while on thalidomide-based triplet regimen for multiple myeloma: a retrospective case series
    Sriskandarajah, P.
    Scott, F. R.
    Muthalali, S.
    Mercieca, J. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 59 - 59
  • [45] Comparison of thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant eligible
    Soutar, R.
    Steel, M.
    Donaldson, A.
    Walbaum, C.
    ANNALS OF HEMATOLOGY, 2020, 99 (04) : 905 - 906
  • [46] Clinical efficacy of thalidomide containing regimens as a first-line therapy in patients with multiple myeloma
    Kim, Y. K.
    Lee, J. J.
    Lee, S. R.
    Shim, H. J.
    Ahn, J. S.
    Yang, D. H.
    Cho, S. H.
    Chung, I. J.
    Kim, D. H.
    Sohn, S. K.
    Shin, H. J.
    Kim, H. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 177 - 177
  • [47] Comparison of thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant eligible
    R Soutar
    M Steel
    A Donaldson
    C Walbaum
    Annals of Hematology, 2020, 99 : 905 - 906
  • [48] Bortezomib-based Triplet Regimens for Remission Induction in Multiple Myeloma
    Toor, Saima Humayun
    Satti, Tariq Mahmood
    Iftikhar, Raheel
    Mahmood, Syed Kamran
    Shamshad, Ghassan Umair
    Rehman, Jahanzeb Ur
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (05): : 527 - 531
  • [49] Predictive factors in peripheral blood stem cell (PBSC) harvest in multiple myeloma (MM) patients.
    Worel, N
    Schlogl, E
    Rabitsch, W
    Kuhrer, I
    Greinix, H
    Hocker, P
    BLOOD, 1997, 90 (10) : 4272 - 4272
  • [50] Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction
    Gertz, Morie A.
    Kumar, Shaji
    Lacy, Martha Q.
    Dispenzieri, Angela
    Dingli, David
    Hayman, Suzanne R.
    Buadi, Francis K.
    Hogan, William J.
    BLOOD, 2010, 115 (12) : 2348 - 2353
12345